Relationship between peroxisome proliferator-activated receptor-γ and renal ischemia-reperfusion injury

Molecular Medicine Reports

Volumn 1, Issue 4, 2008, Pages 499-503

  Matsuyama, Masahide ^a,d   Yoshimura, Rikio ^a,e   Kawahito, Yutaka ^b   Sano, Hajime ^c   Chargui, Jamel ^d   Touraine, Jean Louis ^d   Nakatani, Tatsuya ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

^d UNIVERSITÉ LYON 1   (France)

^e OSAKA CITY UNIVERSITY HOSPITAL   (Japan)

Author keywords

Immunohistochemistry; Peroxisome proliferator activated receptor ; Renal ischemia reperfusion injury

Indexed keywords

MONOCLONAL ANTIBODY; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ACUTE KIDNEY TUBULE NECROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CLAMP; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; ENDOTHELIUM CELL; EPITHELIUM CELL; IMMUNOHISTOCHEMISTRY; KIDNEY COLLECTING TUBULE; KIDNEY ISCHEMIA; KIDNEY NECROSIS; KIDNEY VEIN; LAPAROTOMY; LEYDIG CELL; MALE; MESANGIUM CELL; NONHUMAN; PROTEIN EXPRESSION; RAT; RENAL ARTERY; REPERFUSION INJURY; STAINING;

RATTUS;

EID: 69249124955     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.1.4.499     Document Type: Article

References (17)

1. Matsuyama M, Yoshimura R, Akioka K, Okamato M, Ushigome H, Kadotani Y, Nakatani T and Yoshimura N: Tissue factor antisense oligonucleotides prevent renal ischemia-reperfusion injury. Transplantation 76: 786-791, 2003. (Pubitemid 37140220)
2. 2 induces synoviocyte apotosis and supresses adjuvant-induced arthiritis in rats. J Clin Invest 106: 189-197, 2000.
3. Matsuyama M and Yoshimura R: Prospects of antisense treatment to alleviate renal ischemia-reperfusion injury. Expert Opin Biol Ther 4: 1931-1937, 2004.
4. Inoue K, Kawahito Y, Tsubouchi Y, Kohno M, Yoshimura R, Yoshikawa T and Sano H: Expression of peroxisome proliferator-activated receptor gamma in renal cell carcinoma and growth inhibition by its agonists. Biochem Biophys Res Commun 287: 727-732, 2001. (Pubitemid 32912775)
5. Yoshimura R, Matsuyama M, Segawa Y, Hase T, Mitsuhashi M, Tsuchida K, Wada S, Kawahito Y, Sano H and Nakatani T: Expression of peroxisome proliferator-activated receptors (PPARs) in human urinary bladder carcinoma and growth inhibition by its agonists. Int J Cancer 104: 597-602, 2003. (Pubitemid 36337259)
6. Segawa Y, Yoshimura R, Hase T, Nakatani T, Wada S, Kawahito Y, Kishimoto T and Sano H: Expression of peroxisome proliferator-activated receptor (PPAR) in human prostate cancer. Prostate 51: 108-116, 2002.
7. Hase T, Yoshimura R, Mitsuhashi M, Segawa Y, Kawahito Y, Wada S, Nakatani T and Sano H: Expression of peroxisome proliferator-activated receptors in human testicular cancer and growth inhibition by its agonists. Urology 60: 542-547, 2002. (Pubitemid 35292201)
8. Fitzgerald SM and Flinn S: Evaluating research studies using the analysis of variance (ANOVA): issues and interpretations. J Hand Ther 13: 56-60, 2000. (Pubitemid 30134138)
9. Naito Y, Takagi T, Uchiyama K, Handa O, Tomatsuri N, Imamoto E, Kokura S, Ichikawa H, Yoshida N and Yoshikawa T: Suppression of intestinal ischemia-reperfusion injury by a specific peroxisome proliferator-activated receptor-gamma ligand, pioglitazone, in rats. Redox Rep 7: 294-299, 2002. (Pubitemid 36032917)
10. Sivarajah A, Chatterjee PK, Patel NS, Todorovic Z, Hattori Y, Brown PA, Stewart KN, Mita-Filipe H, Cuzzocrea S and Thiemermann C: Agonists of peroxisome-proliferator activated receptor-gamma reduce renal ischemia/reperfusion injury. Am J Nephrol 23: 267-276, 2003. (Pubitemid 36980722)
11. Yue T-L, Chen J, Bao W, Narayanan PK, Bril A, Jiang W, Lysko PG, Gu J-L, Boyce R, Zimmerman DM, Hart TK, Buckingham RE and Ohlstein EH: In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. Circulation 104: 2588-2594, 2001.
12. Buckingham RE, Al-Barazanji KA, Toseland CD, Slaughter M, Connor SC, West A, Bond B, Turner NC and Clapham JC: Peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zucker fatty rats. Diabetes 47: 1326-1334, 1998. (Pubitemid 28357012)
13. Braissant O, Foufelle F, Scotto C, Dauca M and Wahli W: Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137: 354-366, 1996.
14. Yang T, Michele DE, Park J, Smart AM, Lin Z, Brosius FC III, Schnermann JB and Briggs JP: Expression of peroxisomal proliferator-activated receptors and retinoid X receptors in the kidney. Am J Physiol 277: 966-973, 1999. (Pubitemid 30046072)
15. Iwashima Y, Eto M, Horiuchi S and Sano H: Advanced glycation end product-induced peroxisome proliferator-activated receptor gamma gene expression in the cultured mesangial cells. Biochem Biophys Res Commun 264: 441-448, 1999. (Pubitemid 29516106)
16. Asano T, Wakisaka M, Yoshinari M, Iino K, Sonoki K, Iwase M and Fujishima M: Peroxisome proliferator-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation. Biochim Biophys Acta 1497: 148-154, 2000. (Pubitemid 30330899)
17. Paueksakon P, Revelo MP, Ma LJ, Marcantoni C and Fogo AB: Microangiopathic injury and augmented PAI-1 in human diabetic nephropathy. Kidney Int 61: 2142-2148, 2002. (Pubitemid 34539331)